Cargando…
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
BACKGROUND: Toll-like receptor (TLR)3 ligands serve as natural inducers of pro-inflammatory cytokines capable of promoting Type-1 adaptive immunity, and TLR3 is abundantly expressed by cells within the central nervous system (CNS). To improve the efficacy of vaccine strategies directed against CNS t...
Autores principales: | Zhu, Xinmei, Nishimura, Fumihiko, Sasaki, Kotaro, Fujita, Mitsugu, Dusak, Jill E, Eguchi, Junichi, Fellows-Mayle, Wendy, Storkus, Walter J, Walker, Paul R, Salazar, Andres M, Okada, Hideho |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802742/ https://www.ncbi.nlm.nih.gov/pubmed/17295916 http://dx.doi.org/10.1186/1479-5876-5-10 |
Ejemplares similares
-
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004) -
Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas
por: Okada, Hideho, et al.
Publicado: (2013) -
IFN-γ- and IL-17-producing CD8(+) T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity
por: Ohkuri, Takayuki, et al.
Publicado: (2021) -
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma
por: Ueda, Ryo, et al.
Publicado: (2007) -
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
por: Mehrotra, Shikhar, et al.
Publicado: (2017)